All organisms, from archaea to mammals, have ironcontaining proteins. As a result, the proper management of iron levels in cells is critical for normal physiological function (Lee et al. 2006) . Cells have evolved to accomplish such iron homeostasis by iron's ability to form ligands with various proteins. However, when not properly liganded, iron will show its dark side: unliganded iron can trigger the Fenton reaction, thereby producing highly reactive hydroxyl radicals.
Oxidative stress, one of the most relevant and cuttingedge topics presented in our journal Bolt 2008a, 2008b; Yang et al. 2009; Beyersmann and Hartwig 2008; Adam and Laufs 2008) , is particularly relevant in the brain with its high respiratory activity Kumar and Gill 2009; Verstraeten et al. 2008; Carmo et al. 2006) , liver (Cederbaum et al. 2009; Cervinková et al. 2009; Dewa et al. 2009; Pardo Andreu et al. 2009; Abe et al. 2008; Schober et al. 2009; Bauer et al. 2009; Schumann et al. 2009; Hewitt et al. 2007 ), kidney (Wang et al. 2009 ), lung (Glahn et al. 2008) , and breast cancer (Cadenas et al. 2010 ). In the current issue, Douglas B. Kell from the University of Manchester, UK, presents a comprehensive review demonstrating that many diseases and toxicological insults converge on iron dysregulation. Huntington's, Parkinson's, Gaucher's, Alzheimer's, Creutzfeldt-Jakob's, and Lou Gehrig's disease all seem to involve poorly liganded iron. In addition, iron-based mechanisms contribute to the toxicity of a large number of compounds, including acetaminophen, aniline, asbestos, dioxins, hydrazines, methyl mercury and paraquat. Douglas B. Kell's review is a must-read for anyone interested in the role of dysregulated iron homeostasis and reactive oxygen species in cell/tissue degeneration and toxicity in general.
